Cascara Ventures is a Brussels-based venture capital firm founded in 2016, focusing on seed-stage investments in life sciences companies that leverage technology for healthcare improvements.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Cascara Ventures is a venture capital firm founded in 2016 by Adriaan Hart de Ruijter, an experienced entrepreneur and investor in the life sciences sector. Based in Europe, the firm specializes in seed-stage investments in early-stage companies that apply technology to prevention, therapy, and research in life sciences. Cascara Ventures emphasizes active management of its portfolio, leveraging expertise in regulatory and clinical development to support companies in areas such as vaccines, medical devices, pharmaceuticals, and healthcare software. The firm collaborates with a network of investors and is an accredited investor with the European Investment Fund, allowing it to match investments and support startups through to maturity.
Cascara Ventures specializes in seed-stage investments within the life sciences sector, targeting areas such as vaccines, medical devices, pharmaceuticals, imaging, software, medical data, robotics, healthcare services, diagnostics, and cell therapy. The firm emphasizes active management and collaboration with portfolio companies to drive growth and success.
Cascara Ventures adds value to its portfolio companies through active involvement, including leading investments, taking board seats, and providing strategic, operational, and financial advice. The firm leverages its expertise in regulatory and clinical development to support startups in navigating the complexities of the life sciences industry.
Cascara Ventures focuses on seed-stage investments in the life sciences sector, particularly in technology-driven solutions. They look for companies that address significant healthcare challenges and demonstrate a clear market understanding.
Founders can reach out through the contact form on their website. A well-prepared pitch deck that outlines the business model, market opportunity, and team background is essential.
The firm emphasizes active management and has a strong focus on regulatory and clinical development, which is crucial for life sciences startups. Their collaboration with the European Investment Fund enhances their investment capabilities.
Cascara Ventures primarily invests in early-stage companies based in Europe, ensuring they are well-positioned to support local innovations in life sciences.
Cascara Ventures takes an active role in managing its portfolio companies, providing guidance in regulatory processes and clinical development, which can be critical for success in the life sciences sector.
While specific check sizes are not disclosed, Cascara Ventures focuses on seed-stage investments, which typically range from several hundred thousand to a few million euros, depending on the startup's needs and potential.
Organizations that do similar work to Cascara Ventures.
InvestorDeerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
InvestorAccelerating life sciences innovation in Massachusetts.
InvestorHuman Capital is a multi-stage venture capital firm that partners with exceptional founders to build companies addressing critical industry challenges. They focus on assembling high-caliber teams and deploying capital to support these ventures.
InvestorCLI Ventures is an investment organization based in Palo Alto, California, focusing on early to late-stage startups in sectors like technology and biopharmaceuticals.
Superscout Pro
Is this page right?Reviewed · How the research works